Exscientia business update for first quarter 2023

Oxford, england--(business wire)--exscientia plc (nasdaq: exai) recent advancements in the company's pipeline, collaborations and operations, as well as financial results for the first quarter 2023, are summarised below. exscientia will host a conference call wednesday, may 24 at 1:30 p.m. bst / 8:30 a.m. edt. “with our sixth ai-designed compound reaching the clinical development stage plus two more in active ind/cta-enabling studies, exscientia's pipeline of wholly owned and partnered drug can.
EXAI Ratings Summary
EXAI Quant Ranking